Veterinary Biomarkers Market Report 2025

This veterinary biomarkers market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The veterinary biomarkers market size has grown rapidly in recent years. It will grow from $0.81 billion in 2024 to $0.91 billion in 2025 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to the expansion of the veterinary diagnostics market, increased focus on preventive care, integration of biomarkers in veterinary medicine, increased veterinary research funding, and a rise in veterinary diagnostic labs.

The veterinary biomarkers market size is expected to see rapid growth in the next few years. It will grow to $1.44 billion in 2029 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to the rising prevalence of animal diseases, rising demand for personalized veterinary medicine, growing demand for preventive diagnostics, increasing adoption of digital health tools, and increasing focus on animal welfare regulations. Major trends in the forecast period include advancements in diagnostic technology, advancements in biomarker research, technological advancements in biomarker discovery, the development of user-friendly diagnostic tools, and advancements in personalized nutritional solutions.

The growing trend of pet ownership is expected to drive the expansion of the veterinary biomarkers market in the future. Several factors contribute to the rise in pet ownership, including the desire for companionship, the advantages of pet therapy, and the increasing awareness of the positive effects pets have on both mental and physical health. Veterinary biomarkers play a crucial role in pet ownership by monitoring animal health, facilitating early disease detection, and enabling personalized treatment plans. For instance, in October 2023, the American Pet Products Association, a US-based non-profit organization, reported that 86.9 million households in the United States owned a pet, accounting for 66% of all households in 2022. Similarly, in November 2022, Animal Medicines Australia, an association representing animal health in Australia, noted that 69% of households in Australia owned pets in 2022. Thus, the rise in pet ownership is fueling the growth of the veterinary biomarkers market.

Key players in the veterinary biomarkers sector are actively pursuing strategic partnerships to enhance their market position. These collaborations typically involve partnerships between companies, research institutions, and veterinary practices to advance diagnostic tools and solutions. For instance, in July 2022, Bionote USA, known for its point-of-care testing devices for animal health, teamed up with PSIvet, a veterinary group purchasing organization, to improve access to affordable diagnostic solutions. This partnership allows more than 5,000 veterinary clinics associated with PSIvet to use Bionote's Vcheck analyzers and biomarker tests at reduced costs.

In March 2022, Vimian Group AB, a Swedish animal health company, acquired the veterinary division of Avacta Animal Health for an undisclosed amount. This acquisition supports Vimian Group’s strategy to enhance its presence in the veterinary health market and broaden its service capabilities by leveraging the resources and expertise of Avacta Animal Health, a UK-based diagnostic company specializing in veterinary allergy diagnostic solutions and biomarkers.

Major companies operating in the veterinary biomarkers market are Thermo Fisher Scientific Inc., Boehringer Ingelheim, Merck KGaA, Zoetis Inc., IDEXX Laboratories Inc., Virbac SA, Antech Diagnostics Inc., Neogen Corporation, Heska Corporation, Olink Proteomics, SomaLogic, Life Diagnostics Inc., INDICAL BIOSCIENCE GmbH., Mercodia AB, Bionote USA Inc., Acuvet Biotech, Alertix Veterinary Diagnostics AB, MI:RNA Diagnostics Ltd., Veterinary Biomarkers Inc., Vetmaya Healthcare Private Limited.

North America was the largest region in the veterinary biomarkers market in 2024. The regions covered in the veterinary biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the veterinary biomarkers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Veterinary biomarkers are measurable indicators used to diagnose, monitor, and manage diseases in animals. These can include biological molecules such as proteins, genes, or metabolites that reflect a specific physiological or pathological state. Veterinary biomarkers are essential for early disease detection, evaluating treatment efficacy, and understanding disease mechanisms.

The primary types of veterinary biomarkers include biomarkers themselves, kits and reagents, and biomarker readers. Biomarkers are specific biological molecules or substances used to detect, diagnose, and monitor health conditions in animals. These biomarkers, present in blood, urine, or other body fluids, provide important insights into an animal’s health status. They are used for various diseases, including inflammatory and infectious diseases, cardiovascular diseases, skeletal muscle diseases, tumors, and more. Applications of these biomarkers span disease diagnostics, preclinical research, and other areas, affecting both companion and production animals.

The veterinary biomarkers market research report is one of a series of new reports that provides veterinary biomarkers market statistics, including veterinary biomarkers industry global market size, regional shares, competitors with a veterinary biomarkers market share, detailed veterinary biomarkers market segments, market trends and opportunities, and any further data you may need to thrive in the veterinary biomarkers industry. This veterinary biomarkers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The veterinary biomarkers market consists of sales of biomarker research tools, imaging biomarkers, diagnostic kits, and immunoassays. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.